jump to navigation

Medical device company superDimension raises $24.8 million September 14, 2010

Posted by israelhealthcare in Medical Device, Medical Diagnostic.
Tags:
add a comment

Medical device company superDimension has raised $24.8 million in debt and equity financing in two separate transactions. The capital raise included a $9.8 million equity round of financing and a new $15 million credit facility with Oxford Finance. All of the Company’s existing investors participated in the equity financing, including OrbiMed Advisors, Oxford Biosciences Partners, Pitango Venture Capital, Medica Venture Partners, and Dan Sullivan Investments.

superDimension develops catheter based devices for use in the minimally invasive diagnosis and treatment of early stage lung cancer and other diseases, using the patient’s natural airways to avoid surgery. The superDimension i-Logic system enables physicians to diagnose benign and malignant lung lesions enhancing treatment decisions and avoiding the need for higher-risk procedures.

“Since its commercialization, our i-Logic system has experienced strong physician adoption. Electromagnetic navigation bronchoscopy (ENB) has been performed more than 14,500 times and is used in over 275 hospitals worldwide,” said Daniel J. Sullivan, president and CEO at superDimension. “This additional financing will allow us to further strengthen our commercial infrastructure and sales and marketing team, expanding the benefits of the i-Logic system and ENB to a wider patient population.”

Founded in 1995 by Pinhas Gilboa, superDimension is headquartered in Minneapolis, Minnesota, with other offices located in Dusseldorf, Germany, and Herzliya, Israel. The company has more than 100 employees worldwide.

Sponsored Links – Time Management Tool for Software Testers | Emergency ECG Service Center | Brain Training for ADHD

Advertisements

Medical diagnostic applications developer Pocared Diagnostics raised $10.7 million June 13, 2007

Posted by israelhealthcare in Medical Diagnostic.
add a comment

Medical diagnostic applications developer Pocared Diagnostics raised $10.7 million in a financial round of led by Elron and SCP Vitalife Partners.

“We view Pocared as a highly innovative company presenting an out-of-the-box solution and introducing a disruptive platform technology in the field of real-time IVD,” said Elad Frenkel, Elron’s Director of Business Development.

Pocared provides an innovative solution for real-time, reagentless In-Vitro Diagnostics (IVD). The company wide technological platform may be used to address a wide range of medical and industrial diagnostic applications.

Pocared’s Point-of-Care (POC) diagnostic systems, based upon selective spectrum technology, enable immediate, on-site analysis of human fluids and specimen in order to provide physicians with real-time detection, identification and antibiotic sensitivity of pathogenic bacteria.

Sponsored Links – Medical Distress Alarm System | Healthy Balanced Diet